| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.007 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.083 | 0.007 |